ScoreHaematology

International Prognostic Score for advanced Hodgkin lymphoma (IPS, Hasenclever)

Counts seven adverse factors at diagnosis to estimate 5-year freedom from progression in advanced Hodgkin lymphoma.

Updated 30 October 2026

When to use it

Advanced-stage classical Hodgkin lymphoma (III–IV, or II with B symptoms or bulk depending on protocol) before starting chemotherapy.

What it needs

  • Serum albumin < 4 g/dLYes or no
  • Haemoglobin < 10.5 g/dLYes or no
  • Male sexYes or no
  • Age ≥ 45 yearsYes or no
  • Ann Arbor stage IVYes or no
  • White cells ≥ 15,000/µLYes or no
  • Lymphocytes < 600/µL or < 8 % of white cellsYes or no

The points for each answer and the automatic total are in the app.

How to interpret it

Adverse factors (IPS)
ResultInterpretation
≤ 05-year freedom from progression ≈ 84 %
15-year freedom from progression ≈ 77 %
25-year freedom from progression ≈ 67 %
35-year freedom from progression ≈ 60 %
45-year freedom from progression ≈ 51 %
≥ 55-year freedom from progression ≈ 42 %

Practical tip

It was derived before PET-CT and novel agents; group differences are smaller today, although it is still used to stratify trials.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top